Records containing: Polypoidal Choroidal Vasculopathy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-06A Phase IV, Multicentre, Open-label, Single-arm Study to Investigate the Efficacy, Safety and Durability of Faricimab (RO6867461) in Caucasian Patients With Polypoidal Choroidal Vasculopathy
-
CLINICAL_TRIALS study record update · 2026-02-05Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial
-
CLINICAL_TRIALS study record update · 2025-11-18A Multi-center Randomized Clinical Trial Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT for the Treatment of Polypoidal Choroidal Vasculopathy
-
CLINICAL_TRIALS study record update · 2025-11-18To Determine Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy(PCV)
-
CLINICAL_TRIALS study record update · 2024-02-12Evaluation of the Utility of OCT Angiography in Assessing Vascular Perfusion in Rare Retinal and Choroidal Diseases
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-12-14Tolerating Subretinal Fluid in Type 1 Macular Neovascularization and Polypoidal Choroidal Vasculopathy Treated Using Aflibercept
-
CLINICAL_TRIALS study record update · 2022-12-12Treatment of Polypoidal Choroidal Vasculopathy With High Dose Ranibizumab (Lucentis): A Phase I Safety Study.
-
CLINICAL_TRIALS study record update · 2022-12-06Aflibercept Observational Study for the Clinical Use of PCV in China, Polycentric, Observational, Retrospective-prospective Study
-
CLINICAL_TRIALS study record update · 2022-02-08A Multicenter, Observational, Registrie Study of Conbercept in the Treatment of Polypoidal Choroidal Vasculopathy（START Study）
-
CLINICAL_TRIALS study record update · 2021-08-18An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy Using a Modified Intensive Treat and Extend Regime to a Fixed Dosing Regimen
-
CLINICAL_TRIALS study record update · 2021-01-19Choroid and Choriocapillary Changes in Polypoidal Choroidal Vasculopathy After Intravitreal Anti-VEGF Therapy
-
CLINICAL_TRIALS study record update · 2021-01-15Interval of Disease Inactivity After Complete Polypoidal Regression on ICGA in Eyes With Polypoidal Choroidal Vasculopathy Following Intravitreous Aflibercept Treatment
-
CLINICAL_TRIALS study record update · 2020-05-08A Random, Open-label Multicenter, Phase IV Study Assessing the Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy
-
CLINICAL_TRIALS study record update · 2020-01-10A Randomized, Double-masked, Sham-controlled Phase 4 Study of the Efficacy, Safety, and Tolerability of IV Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With PCV.
-
CLINICAL_TRIALS study record update · 2019-10-10Intraocular Cytokine Changes in Recurrence of Polypoidal Choroidal Vasculopathy
-
CLINICAL_TRIALS study record update · 2019-09-27Using Next-Generation Sequencing Technology to Identify Biomarkers of Common Eye Diseases
-
CLINICAL_TRIALS study record update · 2019-09-19Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy: A Prospective Randomized Multicenter Study
-
CLINICAL_TRIALS study record update · 2019-07-19Efficacy and Safety of Initial Versus Delayed Verteporfin Photodynamic Therapy in Combination With Conbercept in Patients With Symptomatic Polypoidal Choroidal Vasculopathy
-
CLINICAL_TRIALS study record update · 2019-06-07A 24-month, Phase IV, Randomized, Double Masked, Multi-center Study of Ranibizumab Monotherapy or Ranibizumab in Combination With Verteporfin Photodynamic Therapy on Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy
-
CLINICAL_TRIALS study record update · 2018-03-08Comparison of the Effects of Photodynamic Therapy, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen
-
CLINICAL_TRIALS study record update · 2017-12-08ClinicalTrials.gov study NCT02381730
-
CLINICAL_TRIALS study record update · 2017-09-11Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively
-
CLINICAL_TRIALS study record update · 2017-04-25Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases
-
CLINICAL_TRIALS study record update · 2016-11-23Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation
-
CLINICAL_TRIALS study record update · 2016-06-29Analysis of Plasminogen Activator Inhibitor-1 Level in Chronic Serous Chorioretinopathy and Polypoidal Choroidal Vasculopathy